Ladenhauf Valentin, Galijasevic Malik, Regodic Milovan, Helbok Raimund, Rass Verena, Freyschlag Christian, Petr Ondra, Deeg Johannes, Gruber Leonhard, Mangesius Stephanie, Gizewski Elke Ruth, Grams Astrid Ellen
Department of Radiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Neuroimaging Research Core Facility, Medical University of Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria.
Diagnostics (Basel). 2024 Jul 16;14(14):1533. doi: 10.3390/diagnostics14141533.
Aneurysmal wall enhancement (AWE) of non-ruptured sacular intracranial aneurysms (IA) after endovascular treatment (ET) is a frequently observed imaging finding using AWE-sequences in brain magnetic resonance imaging (MRI). So far, its value remains unclear. We aimed to investigate the effect of AWE on aneurysm reperfusion rates in a longitudinal cohort.
This is a retrospective MRI study over the timespan of up to 5 years, assessing the correlation of increased AWE of non-ruptured IAs and events of aneurysm reperfusion and retreatment, PHASES Score and grade of AWE. T1 SPACE fat saturation (FS) and T1 SE FS blood suppression sequences after contrast administration were used for visual interpretation of increased AWE. The IAs' sizes were assessed via the biggest diameter. The grade of enhancement was defined in a grading system from grade 1 to grade 3.
127 consecutive non ruptured IA-patients (58.9 ± 9.0 years, 94 female, 33 male) who underwent elective aneurysm occlusion were included. AWE was observed in 40.2% of patients (51/127) after ET, 6 patients already showed AWE before treatment. In large IAs (which were defined as a single maximum diameter of over 7.5 mm), AWE was significantly associated with aneurysm reperfusion in contrast to large aneurysm without AWE). All grades of AWE were significantly associated with reperfusion.
Our data suggests that in patients with initially large IAs, AWE is correlated with aneurysm reperfusion.
在血管内治疗(ET)后,未破裂的囊状颅内动脉瘤(IA)的瘤壁强化(AWE)是在脑磁共振成像(MRI)中使用AWE序列时经常观察到的影像学表现。到目前为止,其价值仍不明确。我们旨在研究AWE对纵向队列中动脉瘤再灌注率的影响。
这是一项为期长达5年的回顾性MRI研究,评估未破裂IA的AWE增加与动脉瘤再灌注和再治疗事件、PHASES评分以及AWE分级之间的相关性。使用对比剂注射后的T1 SPACE脂肪饱和(FS)和T1 SE FS血液抑制序列对AWE增加进行视觉解读。通过最大直径评估IA的大小。强化程度在1级至3级的分级系统中定义。
纳入了127例连续接受择期动脉瘤闭塞治疗的未破裂IA患者(58.9±9.0岁,94例女性,33例男性)。ET后40.2%的患者(51/127)观察到AWE,6例患者在治疗前已出现AWE。在大型IA(定义为单个最大直径超过7.5 mm)中,与无AWE的大型动脉瘤相比,AWE与动脉瘤再灌注显著相关。所有等级的AWE均与再灌注显著相关。
我们的数据表明,在最初患有大型IA的患者中,AWE与动脉瘤再灌注相关。